Cancer Clinical Trial -Theseus Pharmaceuticals- THE630-21-101

Status:

Open

ClinicalTrials.gov:

NCT05160168

A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Drug

THE-630

Phase

Phase I

Condition

Gastrointestinal Stromal Tumors

Keywords

KIT inhibitor